Tuesday, May 21, 2013 5:13pm EDT
SGEN - Seattle Genetics Inc /wa - Insider Transactions
SIC: 2836 - Biological Products, (no Disgnostic Substances)
CIK: 1060736, EIN: 91-1874389, INC: DE, FY: 12-31
CIK: 1060736, EIN: 91-1874389, INC: DE, FY: 12-31
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
May 10 2013 | SGEN | Seattle Genetics Inc /wa | Akkaraju Srinivas | Director | 17,500 | Option exercise at $12.76 | $223,300 | |
May 10 2013 | SGEN | Seattle Genetics Inc /wa | Akkaraju Srinivas | Director | 17,500 | Sale at $37.17 | $650,430 | |
May 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Option exercise at $10.33 | $20,660 | |
May 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Sale at $36.58 | $73,153 | |
Apr 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Option exercise at $10.33 | $20,660 | |
Apr 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Sale at $35.53 | $71,062 | |
Mar 15 2013 | SGEN | Seattle Genetics Inc /wa | Boerner Christopher S. | SVP, Commercial | 8,500 | Option exercise at $15.10 | $128,350 | |
Mar 15 2013 | SGEN | Seattle Genetics Inc /wa | Boerner Christopher S. | SVP, Commercial | 8,500 | Sale at $33.61 | $285,663 | |
MMar 11 2013 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 50,000 | Option exercise at $12.11 | $605,671 | |
MMar 11 2013 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 60,000 | Sale at $31.16 | $1,869,471 | |
MMar 7 2013 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 49,718 | Sale at $30.75 | $1,528,706 | |
MMar 7 2013 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 20,176 | Option exercise at $12.12 | $244,610 | |
MMar 4 2013 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 100,000 | Option exercise at $12.08 | $1,208,000 | |
MMar 4 2013 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 100,000 | Sale at $29.68 | $2,968,455 | |
Mar 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Option exercise at $10.33 | $20,660 | |
MMar 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 95,750 | Sale at $28.71 | $2,749,017 | |
Feb 25 2013 | SGEN | Seattle Genetics Inc /wa | Gryska David W | Director | 10,000 | Sale at $27.17 | $271,700 | |
MFeb 26 2013 | SGEN | Seattle Genetics Inc /wa | Gryska David W | Director | 10,000 | Option exercise at $6.69 | $66,900 | |
Feb 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Option exercise at $10.33 | $20,660 | |
Feb 1 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 2,000 | Sale at $29.61 | $59,216 | |
MJan 25 2013 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 7,290 | Option exercise at $13.05 | $95,104 | |
MJan 25 2013 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 7,290 | Sale at $30.09 | $219,343 | |
MJan 15 2013 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 125,079 | Option exercise at $11.62 | $1,452,804 | |
MJan 15 2013 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 125,079 | Sale at $28.00 | $3,502,526 | |
MJan 4 2013 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 60,000 | Option exercise at $11.09 | $665,400 | |
Jan 4 2013 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 50,983 | Sale at $24.95 | $1,272,026 | |
MJan 2 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,249 | Option exercise at $5.00 | $41,282 | |
MJan 2 2013 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,249 | Sale at $24.13 | $199,043 | |
MDec 17 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 62,418 | Option exercise at $10.92 | $681,573 | |
Dec 17 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 50,000 | Sale at $23.70 | $1,184,955 | |
MDec 6 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 66,588 | Option exercise at $11.20 | $745,561 | |
MDec 6 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 66,588 | Sale at $25.77 | $1,715,706 | |
MDec 5 2012 | SGEN | Seattle Genetics Inc /wa | Lippman Marc E | Director | 67,500 | Option exercise at $6.83 | $461,325 | |
MDec 5 2012 | SGEN | Seattle Genetics Inc /wa | Lippman Marc E | Director | 67,500 | Sale at $25.54 | $1,723,950 | |
MDec 4 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 40,000 | Option exercise at $12.12 | $484,800 | |
MDec 4 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 40,000 | Sale at $25.59 | $1,023,500 | |
Dec 3 2012 | SGEN | Seattle Genetics Inc /wa | Welch Daniel G | Director | 3,119 | Option exercise at $8.38 | $26,137 | |
Dec 3 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Option exercise at $3.30 | $27,225 | |
Dec 3 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Sale at $25.19 | $207,777 | |
MNov 29 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 40,000 | Option exercise at $12.04 | $481,684 | |
MNov 29 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 40,000 | Sale at $25.41 | $1,016,585 | |
MNov 21 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 30,000 | Option exercise at $13.15 | $394,600 | |
MNov 21 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 30,000 | Sale at $25.34 | $760,100 | |
MNov 19 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 20,000 | Option exercise at $15.32 | $306,314 | |
MNov 19 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 20,000 | Sale at $24.95 | $499,002 | |
MNov 13 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 27,327 | Sale at $23.59 | $644,724 | |
Nov 13 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 24,811 | Option exercise at $10.29 | $255,305 | |
MNov 8 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 72,737 | Option exercise at $5.20 | $378,412 | |
MNov 8 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 34,575 | Option exercise at $6.45 | $223,107 | |
MNov 1 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Option exercise at $5.00 | $41,285 | |
MNov 1 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Sale at $25.51 | $210,476 | |
Oct 15 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 25,000 | Option exercise at $10.29 | $257,250 | |
Oct 15 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 25,000 | Sale at $25.01 | $625,295 | |
MOct 1 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Option exercise at $5.00 | $41,285 | |
MOct 1 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Sale at $26.59 | $219,344 | |
Sep 10 2012 | SGEN | Seattle Genetics Inc /wa | Himes Vaughn B | EVP, Tech. Ops., Proc. Sci. | 10,000 | Option exercise at $9.23 | $92,300 | |
Sep 10 2012 | SGEN | Seattle Genetics Inc /wa | Himes Vaughn B | EVP, Tech. Ops., Proc. Sci. | 10,000 | Sale at $28.79 | $287,900 | |
Sep 6 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 48,540 | Option exercise at $8.24 | $399,970 | |
Sep 6 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 48,540 | Sale at $29.75 | $1,444,065 | |
MSep 5 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 95,000 | Option exercise at $11.69 | $1,110,073 | |
MSep 5 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 95,000 | Sale at $28.50 | $2,707,150 | |
MSep 4 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Option exercise at $5.00 | $41,285 | |
MSep 4 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Sale at $26.54 | $218,958 | |
MAug 24 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 45,000 | Option exercise at $10.52 | $473,551 | |
MAug 24 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 45,000 | Sale at $26.97 | $1,213,650 | |
MAug 23 2012 | SGEN | Seattle Genetics Inc /wa | Berger Franklin M | Director | 20,000 | Option exercise at $10.14 | $202,800 | |
Aug 20 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 20,000 | Grant at $0.00 | $0 | |
Aug 20 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 74,250 | Grant at $0.00 | $0 | |
Aug 20 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 26,000 | Grant at $0.00 | $0 | |
Aug 20 2012 | SGEN | Seattle Genetics Inc /wa | Himes Vaughn B | EVP, Technical Operations | 16,000 | Grant at $0.00 | $0 | |
Aug 20 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 26,000 | Grant at $0.00 | $0 | |
Aug 20 2012 | SGEN | Seattle Genetics Inc /wa | Boerner Christopher S. | SVP, Commercial | 12,000 | Grant at $0.00 | $0 | |
Aug 16 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 40,000 | Option exercise at $10.29 | $411,600 | |
Aug 16 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 40,000 | Sale at $25.97 | $1,038,800 | |
Aug 13 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 25,000 | Sale at $24.01 | $600,290 | |
Aug 10 2012 | SGEN | Seattle Genetics Inc /wa | Gryska David W | Director | 7,500 | Option exercise at $5.00 | $37,500 | |
MAug 1 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Option exercise at $5.00 | $41,285 | |
MAug 1 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Sale at $26.00 | $214,462 | |
Jul 27 2012 | SGEN | Seattle Genetics Inc /wa | Welch Daniel G | Director | 3,000 | Option exercise at $19.02 | $57,060 | |
Mar 19 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 5,000 | Gift at $0.00 | $0 | |
MJul 2 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Option exercise at $5.00 | $41,285 | |
MJul 2 2012 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | President, CEO | 8,250 | Sale at $25.36 | $209,201 | |
Jun 18 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 25,000 | Option exercise at $10.29 | $257,250 | |
Jun 18 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 25,000 | Sale at $25.36 | $634,000 | |
Jun 12 2012 | SGEN | Seattle Genetics Inc /wa | Rosenberg Morris | EVP, Process Sciences | 10,000 | Option exercise at $10.29 | $102,900 | |
Jun 12 2012 | SGEN | Seattle Genetics Inc /wa | Rosenberg Morris | EVP, Process Sciences | 10,000 | Sale at $24.00 | $240,000 | |
MJun 12 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 95,000 | Option exercise at $5.29 | $502,421 | |
MJun 12 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 95,000 | Sale at $24.50 | $2,327,285 | |
Jun 8 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 35,000 | Option exercise at $5.20 | $182,000 | |
Jun 8 2012 | SGEN | Seattle Genetics Inc /wa | Simpson Todd E | CFO | 35,000 | Sale at $22.97 | $803,950 | |
Jun 7 2012 | SGEN | Seattle Genetics Inc /wa | Rosenberg Morris | EVP, Process Sciences | 13,566 | Option exercise at $10.29 | $139,594 | |
Jun 7 2012 | SGEN | Seattle Genetics Inc /wa | Rosenberg Morris | EVP, Process Sciences | 13,566 | Sale at $22.50 | $305,235 | |
Jun 5 2012 | SGEN | Seattle Genetics Inc /wa | Gryska David W | Director | 8,000 | Sale at $19.75 | $158,000 | |
MMay 16 2012 | SGEN | Seattle Genetics Inc /wa | Rosenberg Morris | EVP, Process Sciences | 65,000 | Option exercise at $4.45 | $289,250 | |
MMay 16 2012 | SGEN | Seattle Genetics Inc /wa | Rosenberg Morris | EVP, Process Sciences | 65,000 | Sale at $21.54 | $1,399,776 | |
May 15 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 949 | Option exercise at $8.24 | $7,820 | |
May 15 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 949 | Sale at $19.75 | $18,743 | |
Apr 25 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 40,000 | Option exercise at $8.24 | $329,600 | |
Apr 25 2012 | SGEN | Seattle Genetics Inc /wa | Reynolds Thomas C | Chief Medical Officer | 40,000 | Sale at $19.75 | $790,000 | |
MApr 25 2012 | SGEN | Seattle Genetics Inc /wa | Dobmeier Eric | COO | 25,000 | Option exercise at $10.24 | $255,957 |
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance